Updated:
Sigilon Therapeutics, Inc.
Sigilon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001821323, and its reported...
Overview
Sigilon Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001821323, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2023-03-14, it reported annual revenue of USD 12,944,000; net income of USD -43,561,000; total assets of USD 87,278,000 for the fiscal period ended 2022-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Sigilon Therapeutics, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- Cambridge, MA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001821323
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Revenue | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|---|
| FY2022USD | $12.9M | -$43.6M | $87.3M | $42.1M | -$51.5M | |
| FY2021USD | $9.6M | -$77.3M | $144.4M | $107.1M | -$78.4M |
FY2022. Net income: shown as originally filed; later filings report different values for the same periods.
FY2021. Net income: shown as originally filed; later filings report different values for the same periods.
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| SC 13D | — | SC 13D | |
| 8-K | FORM 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| DEF 14A | DEF 14A | ||
| 10-K | 10-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Sigilon Therapeutics, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.